Titre : Boraginaceae

Boraginaceae : Questions médicales fréquentes

Termes MeSH sélectionnés :

Neoadjuvant Therapy
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Boraginaceae : Questions médicales les plus fréquentes", "headline": "Boraginaceae : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Boraginaceae : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-13", "dateModified": "2025-04-08", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Boraginaceae" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Magnoliopsida", "url": "https://questionsmedicales.fr/mesh/D019684", "about": { "@type": "MedicalCondition", "name": "Magnoliopsida", "code": { "@type": "MedicalCode", "code": "D019684", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B01.875.800.575.912.250" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Amsinckia", "alternateName": "Amsinckia", "url": "https://questionsmedicales.fr/mesh/D029682", "about": { "@type": "MedicalCondition", "name": "Amsinckia", "code": { "@type": "MedicalCode", "code": "D029682", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B01.875.800.575.912.250.150.122" } } }, { "@type": "MedicalWebPage", "name": "Borago", "alternateName": "Borago", "url": "https://questionsmedicales.fr/mesh/D029683", "about": { "@type": "MedicalCondition", "name": "Borago", "code": { "@type": "MedicalCode", "code": "D029683", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B01.875.800.575.912.250.150.188" } } }, { "@type": "MedicalWebPage", "name": "Consoude", "alternateName": "Comfrey", "url": "https://questionsmedicales.fr/mesh/D020844", "about": { "@type": "MedicalCondition", "name": "Consoude", "code": { "@type": "MedicalCode", "code": "D020844", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B01.875.800.575.912.250.150.210" } } }, { "@type": "MedicalWebPage", "name": "Cordia", "alternateName": "Cordia", "url": "https://questionsmedicales.fr/mesh/D031213", "about": { "@type": "MedicalCondition", "name": "Cordia", "code": { "@type": "MedicalCode", "code": "D031213", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B01.875.800.575.912.250.150.327" } } }, { "@type": "MedicalWebPage", "name": "Echium", "alternateName": "Echium", "url": "https://questionsmedicales.fr/mesh/D036661", "about": { "@type": "MedicalCondition", "name": "Echium", "code": { "@type": "MedicalCode", "code": "D036661", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B01.875.800.575.912.250.150.385" } } }, { "@type": "MedicalWebPage", "name": "Eriodictyon", "alternateName": "Eriodictyon", "url": "https://questionsmedicales.fr/mesh/D031322", "about": { "@type": "MedicalCondition", "name": "Eriodictyon", "code": { "@type": "MedicalCode", "code": "D031322", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B01.875.800.575.912.250.150.415" } } }, { "@type": "MedicalWebPage", "name": "Heliotropium", "alternateName": "Heliotropium", "url": "https://questionsmedicales.fr/mesh/D028162", "about": { "@type": "MedicalCondition", "name": "Heliotropium", "code": { "@type": "MedicalCode", "code": "D028162", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B01.875.800.575.912.250.150.444" } } }, { "@type": "MedicalWebPage", "name": "Lithospermum", "alternateName": "Lithospermum", "url": "https://questionsmedicales.fr/mesh/D029684", "about": { "@type": "MedicalCondition", "name": "Lithospermum", "code": { "@type": "MedicalCode", "code": "D029684", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B01.875.800.575.912.250.150.501" } } }, { "@type": "MedicalWebPage", "name": "Pulmonaria", "alternateName": "Pulmonaria", "url": "https://questionsmedicales.fr/mesh/D029685", "about": { "@type": "MedicalCondition", "name": "Pulmonaria", "code": { "@type": "MedicalCode", "code": "D029685", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B01.875.800.575.912.250.150.750" } } } ], "about": { "@type": "MedicalCondition", "name": "Boraginaceae", "alternateName": "Boraginaceae", "code": { "@type": "MedicalCode", "code": "D028082", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Maryam Noroozi", "url": "https://questionsmedicales.fr/author/Maryam%20Noroozi", "affiliation": { "@type": "Organization", "name": "Department of Ecology & Evolutionary Biology, University of Tennessee, Knoxville, TN, 37996, USA." } }, { "@type": "Person", "name": "Farrokh Ghahremaninejad", "url": "https://questionsmedicales.fr/author/Farrokh%20Ghahremaninejad", "affiliation": { "@type": "Organization", "name": "Department of Plant Sciences, Faculty of Biological Sciences, Kharazmi University, Tehran, 15719-14911, Iran. fgh@khu.ac.ir." } }, { "@type": "Person", "name": "Mehrshid Riahi", "url": "https://questionsmedicales.fr/author/Mehrshid%20Riahi", "affiliation": { "@type": "Organization", "name": "Department of Plant Sciences, Faculty of Biological Sciences, Kharazmi University, Tehran, 15719-14911, Iran." } }, { "@type": "Person", "name": "James I Cohen", "url": "https://questionsmedicales.fr/author/James%20I%20Cohen", "affiliation": { "@type": "Organization", "name": "Department of Botany and Plant Ecology, Weber State University, 1415 Edvalson St., Dept. 2504, Ogden, UT, 84408, USA." } }, { "@type": "Person", "name": "José Luis Guil-Guerrero", "url": "https://questionsmedicales.fr/author/Jos%C3%A9%20Luis%20Guil-Guerrero", "affiliation": { "@type": "Organization", "name": "Food Technology Division, University of Almería, 04120, Almería, Spain." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Histological tumor necrosis in pancreatic cancer after neoadjuvant therapy.", "datePublished": "2022-05-18", "url": "https://questionsmedicales.fr/article/35583018", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3892/or.2022.8332" } }, { "@type": "ScholarlyArticle", "name": "Preoperative stereotactic radiosurgery as neoadjuvant therapy for resectable brain tumors.", "datePublished": "2023-10-27", "url": "https://questionsmedicales.fr/article/37889441", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11060-023-04466-5" } }, { "@type": "ScholarlyArticle", "name": "Neoadjuvant Targeted Therapy in Resectable NSCLC: Current and Future Perspectives.", "datePublished": "2023-07-13", "url": "https://questionsmedicales.fr/article/37451404", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jtho.2023.07.006" } }, { "@type": "ScholarlyArticle", "name": "Biliary Adverse Events During Neoadjuvant Therapy for Pancreatic Cancer.", "datePublished": "2023-04-20", "url": "https://questionsmedicales.fr/article/37078282", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/SLA.0000000000005884" } }, { "@type": "ScholarlyArticle", "name": "Neoadjuvant therapy in pancreatic cancer: a review and update on recent trials.", "datePublished": "2022-07-15", "url": "https://questionsmedicales.fr/article/35881969", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/MOG.0000000000000874" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Eucaryotes", "item": "https://questionsmedicales.fr/mesh/D056890" }, { "@type": "ListItem", "position": 3, "name": "Viridiplantae", "item": "https://questionsmedicales.fr/mesh/D057948" }, { "@type": "ListItem", "position": 4, "name": "Streptophyta", "item": "https://questionsmedicales.fr/mesh/D057949" }, { "@type": "ListItem", "position": 5, "name": "Embryophyta", "item": "https://questionsmedicales.fr/mesh/D019669" }, { "@type": "ListItem", "position": 6, "name": "Tracheobionta", "item": "https://questionsmedicales.fr/mesh/D064028" }, { "@type": "ListItem", "position": 7, "name": "Magnoliopsida", "item": "https://questionsmedicales.fr/mesh/D019684" }, { "@type": "ListItem", "position": 8, "name": "Boraginaceae", "item": "https://questionsmedicales.fr/mesh/D028082" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Boraginaceae - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Boraginaceae", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-05", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Boraginaceae", "description": "Comment identifier les plantes de la famille Boraginaceae ?\nQuels tests pour évaluer l'efficacité des Boraginaceae ?\nY a-t-il des critères spécifiques pour le diagnostic ?\nComment distinguer les Boraginaceae des autres familles ?\nQuels outils pour identifier les Boraginaceae ?", "url": "https://questionsmedicales.fr/mesh/D028082?mesh_terms=Neoadjuvant+Therapy&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Boraginaceae", "description": "Quels symptômes sont associés à l'utilisation des Boraginaceae ?\nLes Boraginaceae provoquent-elles des effets indésirables ?\nQuels symptômes d'intoxication peuvent survenir ?\nComment reconnaître une réaction allergique aux Boraginaceae ?\nLes Boraginaceae peuvent-elles causer des troubles respiratoires ?", "url": "https://questionsmedicales.fr/mesh/D028082?mesh_terms=Neoadjuvant+Therapy&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Boraginaceae", "description": "Comment éviter les effets indésirables des Boraginaceae ?\nQuelles précautions prendre avant d'utiliser des Boraginaceae ?\nLes Boraginaceae peuvent-elles interagir avec d'autres médicaments ?\nComment stocker les préparations à base de Boraginaceae ?\nY a-t-il des recommandations pour l'utilisation des Boraginaceae ?", "url": "https://questionsmedicales.fr/mesh/D028082?mesh_terms=Neoadjuvant+Therapy&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Boraginaceae", "description": "Comment les Boraginaceae sont-elles utilisées en médecine ?\nQuels remèdes à base de Boraginaceae existent ?\nLes Boraginaceae sont-elles efficaces contre l'inflammation ?\nComment préparer un remède à base de Boraginaceae ?\nY a-t-il des contre-indications pour les traitements à base de Boraginaceae ?", "url": "https://questionsmedicales.fr/mesh/D028082?mesh_terms=Neoadjuvant+Therapy&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Boraginaceae", "description": "Quelles complications peuvent survenir avec les Boraginaceae ?\nLes Boraginaceae peuvent-elles causer des problèmes hépatiques ?\nComment gérer une réaction allergique aux Boraginaceae ?\nY a-t-il des risques d'intoxication avec les Boraginaceae ?\nLes Boraginaceae peuvent-elles aggraver des maladies existantes ?", "url": "https://questionsmedicales.fr/mesh/D028082?mesh_terms=Neoadjuvant+Therapy&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Boraginaceae", "description": "Qui est à risque d'allergies aux Boraginaceae ?\nLes femmes enceintes doivent-elles éviter les Boraginaceae ?\nQuels facteurs augmentent le risque d'intoxication ?\nLes personnes âgées sont-elles plus vulnérables ?\nY a-t-il des risques pour les personnes atteintes de maladies chroniques ?", "url": "https://questionsmedicales.fr/mesh/D028082?mesh_terms=Neoadjuvant+Therapy&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier les plantes de la famille Boraginaceae ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Les Boraginaceae se caractérisent par des fleurs en grappes et des feuilles alternées." } }, { "@type": "Question", "name": "Quels tests pour évaluer l'efficacité des Boraginaceae ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des études cliniques et des tests in vitro sont utilisés pour évaluer leur efficacité." } }, { "@type": "Question", "name": "Y a-t-il des critères spécifiques pour le diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'identification botanique et l'analyse des propriétés médicinales." } }, { "@type": "Question", "name": "Comment distinguer les Boraginaceae des autres familles ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'observation des caractéristiques florales et des feuilles aide à la distinction." } }, { "@type": "Question", "name": "Quels outils pour identifier les Boraginaceae ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des guides botaniques et des applications de reconnaissance de plantes sont utiles." } }, { "@type": "Question", "name": "Quels symptômes sont associés à l'utilisation des Boraginaceae ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des réactions allergiques, des troubles gastro-intestinaux ou des effets secondaires peuvent survenir." } }, { "@type": "Question", "name": "Les Boraginaceae provoquent-elles des effets indésirables ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines espèces peuvent causer des effets indésirables comme des nausées." } }, { "@type": "Question", "name": "Quels symptômes d'intoxication peuvent survenir ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes tels que des vomissements, des douleurs abdominales peuvent apparaître." } }, { "@type": "Question", "name": "Comment reconnaître une réaction allergique aux Boraginaceae ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des démangeaisons, éruptions cutanées ou œdème peuvent indiquer une allergie." } }, { "@type": "Question", "name": "Les Boraginaceae peuvent-elles causer des troubles respiratoires ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles respiratoires peuvent survenir en cas d'allergie ou d'intoxication." } }, { "@type": "Question", "name": "Comment éviter les effets indésirables des Boraginaceae ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il est conseillé de commencer par de faibles doses et de surveiller les réactions." } }, { "@type": "Question", "name": "Quelles précautions prendre avant d'utiliser des Boraginaceae ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Consulter un professionnel de santé avant utilisation, surtout en cas de maladies préexistantes." } }, { "@type": "Question", "name": "Les Boraginaceae peuvent-elles interagir avec d'autres médicaments ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent interagir avec certains médicaments, il est donc important de vérifier." } }, { "@type": "Question", "name": "Comment stocker les préparations à base de Boraginaceae ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Conserver dans un endroit frais et sec, à l'abri de la lumière pour préserver l'efficacité." } }, { "@type": "Question", "name": "Y a-t-il des recommandations pour l'utilisation des Boraginaceae ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Suivre les recommandations d'un professionnel de santé et respecter les dosages conseillés." } }, { "@type": "Question", "name": "Comment les Boraginaceae sont-elles utilisées en médecine ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont utilisées pour traiter des inflammations, des douleurs et des troubles cutanés." } }, { "@type": "Question", "name": "Quels remèdes à base de Boraginaceae existent ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des infusions, des pommades et des extraits sont couramment utilisés." } }, { "@type": "Question", "name": "Les Boraginaceae sont-elles efficaces contre l'inflammation ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études montrent qu'elles peuvent réduire l'inflammation et la douleur." } }, { "@type": "Question", "name": "Comment préparer un remède à base de Boraginaceae ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les feuilles peuvent être infusées ou utilisées en cataplasme pour des applications topiques." } }, { "@type": "Question", "name": "Y a-t-il des contre-indications pour les traitements à base de Boraginaceae ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines personnes, comme les femmes enceintes, doivent éviter leur utilisation." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec les Boraginaceae ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des allergies sévères ou des troubles gastro-intestinaux peuvent survenir." } }, { "@type": "Question", "name": "Les Boraginaceae peuvent-elles causer des problèmes hépatiques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines espèces contiennent des composés toxiques pouvant affecter le foie." } }, { "@type": "Question", "name": "Comment gérer une réaction allergique aux Boraginaceae ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Cesser l'utilisation immédiatement et consulter un médecin si les symptômes persistent." } }, { "@type": "Question", "name": "Y a-t-il des risques d'intoxication avec les Boraginaceae ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une consommation excessive peut entraîner des symptômes d'intoxication." } }, { "@type": "Question", "name": "Les Boraginaceae peuvent-elles aggraver des maladies existantes ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent aggraver certaines conditions, comme les maladies hépatiques ou rénales." } }, { "@type": "Question", "name": "Qui est à risque d'allergies aux Boraginaceae ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes ayant des antécédents d'allergies aux plantes sont plus à risque." } }, { "@type": "Question", "name": "Les femmes enceintes doivent-elles éviter les Boraginaceae ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il est recommandé qu'elles évitent leur utilisation en raison de risques potentiels." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque d'intoxication ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Une consommation excessive ou l'utilisation de préparations non contrôlées augmentent le risque." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus vulnérables ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent être plus sensibles aux effets indésirables des Boraginaceae." } }, { "@type": "Question", "name": "Y a-t-il des risques pour les personnes atteintes de maladies chroniques ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes atteintes de maladies chroniques doivent être prudentes avec leur utilisation." } } ] } ] }

Sources (10000 au total)

Preoperative stereotactic radiosurgery as neoadjuvant therapy for resectable brain tumors.

Stereotactic radiosurgery (SRS) is a method of delivering conformal radiation, which allows minimal radiation damage to surrounding healthy tissues. Adjuvant radiation therapy has been shown to improv... PubMed was systemically reviewed using the search terms "neoadjuvant radiosurgery", "brain metastasis", and "glioma". ' Clinicaltrials.gov ' was also reviewed to include ongoing phase III trials.... This comprehensive review describes the evolving role for neoadjuvant SRS in the treatment for brain metastases, gliomas, and benign etiologies. We also discuss the potential role for high LET radiati... Early clinical data is very promising for neoadjuvant SRS in the setting of brain metastases. There are three ongoing phase III trials that will be more definitive in evaluating the potential benefits...

Biliary Adverse Events During Neoadjuvant Therapy for Pancreatic Cancer.

To describe a high-volume experience with biliary drainage before neoadjuvant therapy (NAT) for patients with operable pancreatic cancer (PC) and characterize the association between biliary adverse e... Patients with PC presenting with biliary obstruction require durable decompression before NAT.... Patients with operable PC and tumor-associated biliary obstruction were examined and grouped by the presence or absence of a BAE during NAT. The incidence, timing, and management of BAEs are described... Of 426 patients who received pretreatment biliary decompression, 92 (22%) experienced at least 1 BAE during NAT, and 56 (13%) required repeat intervention on their biliary stent. The median duration o... During extended multimodal NAT for PC, 22% of patients experienced a BAE. Although BAEs were not associated with a significant interruption of treatment, patients who experienced a BAE had worse OS....

Neoadjuvant therapy in pancreatic cancer: a review and update on recent trials.

Neoadjuvant therapy (NAT) has been enthusiastically embraced for patients with operable pancreatic cancer (PDAC) in hopes of improving survival. However, the rapid integration of clinical trial data h... The results of ESPAC-5F, NEOLAP-AIO-PAK-0113, SWOG1505, PREOPANC, HyperAcutePancreas, and ALLIANCE A021501 are reviewed in detail. These studies sequentially evaluate the different neoadjuvant treatme... NAT is associated with improved survival for patients with borderline resectable PDAC but broader efficacy for resectable PDAC and optimal treatment strategy have yet to be defined....

Patient Survival With ypT0N+ Following Neoadjuvant Therapy in Rectal Cancer.

After neoadjuvant therapy, pathologic analysis of rectal cancer resected specimens may show a complete response in the primary tissue cancer with residual tumor in the lymph nodes (ypT0N+).... The aim of this study was to describe the 5-year overall survival and factors associated with survival of ypT0N+ patients with rectal cancer who had neoadjuvant therapy followed by surgery and to comp... We conducted a retrospective analysis.... We used the National Cancer Database.... We identified patients with rectal adenocarcinoma who underwent total neoadjuvant therapy or neoadjuvant chemoradiation followed by surgery between 2006 and 2016. Besides ypT0N+, 5 pathologic categori... The primary outcome measure was 5-year overall survival.... We included 30,751 patients with rectal adenocarcinoma. A total of 342 patients developed ypT0N+, of whom 181 (52.9%) received total neoadjuvant therapy. Among patients who received total neoadjuvant ... Limitations include the retrospective nature of this study, lack of variables describing the chemotherapy and radiation regimens used, and paucity of data on disease-specific survival or recurrence.... Developing ypT0N+ was associated with a lower 5-year overall survival than ypT0N0 and ypT1-2N0. However, it was associated with a higher 5-year overall survival than ypT3-4N+. See Video Abstract at ht... ANTECEDENTES:Después del tratamiento neoadyuvante en el cáncer de recto bajo, el análisis patológico de la pieza operatoria resecada, puede mostrar una respuesta patológica completa del tumor primario...

Neoadjuvant Therapy Regimens for Hilar Cholangiocarcinoma Before Liver Transplant.

Patients with unresectable hilar cholangiocarcinoma (hCCA) may be eligible for curative treatment through liver transplantation (LT). Neoadjuvant protocols often include radiotherapy (RT), however, th... A survey was administered to radiation oncologists practicing at LT centers identified through the U.S. Organ Procurement and Transplant Network and the International Cholangiocarcinoma Research Netwo... Twenty-three centers utilizing neoadjuvant therapy for hCCA were identified. Most respondents (96%) use both chemotherapy and RT as part of their protocol. Elective nodal volumes commonly included the... These results suggest significant variability of neoadjuvant RT use for hCCA before LT. A wide range of doses and fractionation schemes are utilized with cumulative doses ranging from 40 to 110 Gy (EQ...